Daniel Ryweck
Fortuna: 2 068 $ al 30/06/2026
Fortuna: 2 068 $ al 30/06/2026
Mr. Daniel E.
Ryweck is a Chief Financial Officer at Silo Pharma, Inc. Mr. Ryweck was previously employed as a Chief Financial Officer by Sun BioPharma, Inc. and a Controller by SUI Group Holdings Ltd. He also served on the board at Dala Petroleum Corp.
and KonaTel, Inc. He received his undergraduate degree from The Curtis L.
Carlson School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SILO PHARMA INC 0,03 % | 25/08/2025 | 333 ( 0,03 % ) | 2 068 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SILO PHARMA, INC. | Director Financiero/CFO | 27/09/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Dala Petroleum Corp.
Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Director/Miembro de la Junta | 31/08/2017 |
| KONATEL, INC. | Director/Miembro de la Junta | 31/08/2017 |
| SUN BIOPHARMA INC | Director Financiero/CFO | 01/09/2015 |
| SUI GROUP HOLDINGS LIMITED | Oficial de Cumplimiento | 31/12/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Mill City Ventures III Ltd.
Mill City Ventures III Ltd. Finance/Rental/LeasingFinance Provides short-term finance solutions to private businesses, micro and small-cap public companies and high-net-worth individuals | Finance |
Silo Pharma, Inc.
Silo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a developmental stage biopharmaceutical company that focuses on merging traditional therapeutics with psychedelic research | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dala Petroleum Corp.
Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Energy Minerals |
Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
KonaTel, Inc.
KonaTel, Inc. Wireless TelecommunicationsCommunications Provides hosted communication platform as a service and mobile solutions | Communications |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.